ATAI
NASDAQ · Pharmaceuticals
Ataibeckley Inc
$3.54
+0.16 (+4.73%)
Open$3.37
Previous Close$3.38
Day High$3.65
Day Low$3.37
52W High$6.75
52W Low$1.15
Volume—
Avg Volume5.59M
Market Cap1.30B
P/E Ratio—
EPS$-2.30
SectorPharmaceuticals
Analyst Ratings
Strong Buy
19 analysts
Price Target
+1,042.4% upside
Current
$3.54
$3.54
Target
$40.44
$40.44
$27.58
$40.44 avg
$50.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.62M | 2.70M | 436.73M |
| Net Income | -1,065,745,685 | -1,191,899,115 | 64.85M |
| Profit Margin | -16,142.0% | -46,040.8% | 14.9% |
| EBITDA | -1,073,500,021 | -1,216,403,523 | 102.81M |
| Free Cash Flow | — | — | 81.44M |
| Rev Growth | +161.0% | -75.3% | -6.2% |
| Debt/Equity | — | 0.20 | 0.24 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |